Condition (MeSH)
Polydactyly
ClinicalTrials.gov lists 5 trials for Polydactyly or a narrower condition beneath it. National Human Genome Research Institute (NHGRI) has the most among industry and government lead sponsors, with 2.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
5 of the 5 trials are tagged with Polydactyly itself; the rest are tagged with a narrower condition beneath it.
When did Polydactyly trials start? (5)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 4
- Observational
Top of scale: 1
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2024 | 1 |
| 2022 | 1 |
| 2021 | 1 |
| 2004 | 1 |
| 1994 | 1 |
No forecast is made for this condition: it averages 0.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Polydactyly trials in? (2)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 4 | 1 |
| Observational | 4 |
How many Polydactyly trials are recruiting? (4)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Active, not recruiting | 1 |
| Completed | 2 |
| Terminated | 1 |
| Unknown status | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Polydactyly trials? (2)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| National Human Genome Research Institute (NHGRI) | 2 |
| Rolfs Consulting und Verwaltungs-GmbH (RCV) | 1 |
Which publications cover Polydactyly? (13)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Bardet-Biedl syndrome: a case series. | Journal of medical case reports | 2022 | Yes |
| Preoperative angulation as a predictor for operations of Wassel type IV polydactyly. | Journal of pediatric orthopedics. Part B | 2021 | Yes |
| A clinically weighted approach to outcome assessment in radial polydactyly. | The Journal of hand surgery, European volume | 2016 | Yes |
| Use of an Axial Flap to Increase the Girth of Wassel IV Thumb Reconstructions. | The Journal of hand surgery | 2015 | Yes |
| Surgical reconstruction in Wassel type IV thumb duplication. | Acta orthopaedica et traumatologica turcica | 2014 | Yes |
Showing 5 of 13 publications.
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Non-syndromic polydactyly | 2913 | Exact | Orphadata Science knowledge files, Product 1 |
| Non-syndromic polydactyly | 2913 | Exact | Orphanet Rare Disease Ontology (ORDO) |
Sub-conditions in MeSH (1)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials and prevalence.
Not computed for conditions with fewer than 10 trials: drugs tested.